awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38783203-0019F4ED-4B95-43FA-A955-646912068CEF
Q38783203-0019F4ED-4B95-43FA-A955-646912068CEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38783203-0019F4ED-4B95-43FA-A955-646912068CEF
Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes.
P2860
Q38783203-0019F4ED-4B95-43FA-A955-646912068CEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38783203-0019F4ED-4B95-43FA-A955-646912068CEF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fc912ea751e768fab22d40188f49542dc790d9df
P2860
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)